For the PbAc2 recipe, the changes in stoichiometry were performed by adding a MAI/DMF stock solution into precisely known volumes of MAI:PbAc2/DMF perovskite solution. In order to perform controlled stoichiometric changes, it is necessary to know the total solid concentration in each of the solutions.
For the PbAc2 recipe, the changes in stoichiometry were performed by adding a MAI/DMF stock solution into precisely known volumes of MAI:PbAc2/DMF perovskite solution. In order to perform controlled stoichiometric changes, it is necessary to know the total solid concentration in each of the solutions. Therefore, the density of the two solutions was determined in the following fashion:
For the MAI/DMF stock solution, 385.5 mg MAI was dissolved in 1 ml DMF (29 wt%). The density of this solution was determined (by weighing exactly known volumes) to be 1145 mg/ml, i.e. a solid concentration of 332.1 mg/ml MAI.
For the perovskite solution, carefully weighed amounts of MAI and PbAc2 were dissolved in DMF at 42 wt% with a certain stoichiometry y. After addition of HPA (6.43 ul / 1 ml DMF) with a density of 1.206 mg/ml, the weight percentage of perovskite (MAI+PbAc2) decreases to 41.8%. The density for various stoichiometries was determined by weighing.
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Once the density of the perovskite solution and the perovskite weight percentage are known, the solid concentration as well as the amount of PbAc2 per sample (40 µl) can be calculated for each stoichiometry y. The weight of PbAc2 in the remaining precursor solution was calculated for each step and suitable amounts of MAI/DMF stock solution were added to perform the desired changes in stoichiometry y (see Table S1 for an example calculation, and Fig. S13, S14 and S16 for the results using this recipe). This is by far the most reproducible and accurate method to perform controlled stoichiometric changes and furthermore it allows the use of the same precursor solution for a complete batch. While changing the precursor stoichiometry is in principle also possible by weighing slightly different amounts of each of the precursors into individual solutions, our experience shows that human error when weighing various compounds in the same vial is often underestimated and that even with extreme care and attention, this method is less accurate than the one described above and used in this study.
As the initial precursor weighing and the pipetting using calibrated Gilson Pipetman Microman E pipettes (for determining the density as well as performing changes in stoichiometry) both introduce small errors on the order of ~0.1% and ~1%, respectively, we were able to estimate the systematic error for each stoichiometry y. As an example, using the values in Table S1 , even in the extreme case that the actual volume per sample was 38 µl instead of the supposed 40 µl (5% relative error), the final stoichiometry after 5 variation steps would still be y = 3.0579 instead of y = 3.06 which represents an error of only y = 0.0021 (see Table S2 ).
For the MAPI solvent quenching recipe, again the density of the perovskite solution and the stock solution, containing PbI2:MAI (0.95:1) and MAI (both dissolved in DMF/DMSO (4:1, v:v), with 42.96 wt % and 40 wt %, respectively), was determined by weighing to calculate the solid concentration in the solutions.
Suitable amounts of stock solution were added to the starting perovskite solution to vary the stoichiometry z = PbI2:MAI as presented in Fig. S13 and For the CsFAMA recipe, the parameter space for performing stoichiometric variations around the stoichiometric Cs0.05(FA0.83MA0.17)0.95Pb(I0.9Br0.1)3 (with z = Cs0.05(FA0.83MA0.17)0.95I:Pb(I0.85Br0.15)2 = 1) is even bigger. In order to keep it simple, we varied the amount of excess Pb(I0.85Br0.15)2, which represents the typical 'lead excess' in many publications, or the amount of excess FAI0.83MAI0.17 in the precursor solution.
Same as for the PbAc2 recipe, the density of the two stock solutions containing Pb(I0.85Br0.15)2 and FAI0.83MAI0.17 as well as that of the perovskite precursor 
Supplementary Note 2:

Modified Williamson-Hall method for microstrain estimation
Broadening and shifts in the XRD peak can be caused by either a reduction in the grain size (Scherrer broadening) and/or non-uniform strain (microstrain). We note that Scherrer broadening will only be significant when the grains are in the range of or less than 100nm, and as we will discuss later we do not expect this to be a significant contribution here. Strain is the relative change in size of an object with respect to its ideal size (or size before experiencing an external force). The microstrain in a crystalline material is a result of small fluctuations in the lattice spacing, induced by crystal imperfections/structural defects including dislocations, vacancies, stacking faults, interstitials, twinning, and grain boundaries. 1,2,3 By simply considering Braggs law for scattering of light of wavelength λ, nλ = 2dsinθ, it is clear that small fluctuations in d (i.e. d) will result in small fluctuations, or broadening, in θ when measuring the X-ray diffraction from the material. We quantify the extent of microstrain in our perovskite crystals by analysing the peak broadening in the diffraction patterns according to the modified Williamson-Hall method. 2, 4 The effective observed dspace broadening ( dobs) determined from the XRD peak width broadening, is a convoluted function of the Gaussian full width half maximum broadening in the 2θ scan due to the instrument response ( dins), the grain size ( dsize) and the microstrain ( dε). These can be de-convoluted from the observed broadening, via,
(1)
where the unit-less microstrain ε is defined as ε = ( dε/ ), where d is the mean d-spacing.
For single crystals, the size effect induced peak width broadening can be neglected, hence if d 2 size << d 2 obs 19 and we can write,
Therefore, the slope of ( d 2 obsd 2 ins) 1/2 versus d, gives the magnitude of the microstrain, ε, in the crystals. Supplementary Table 1 : Example calculation for performing changes in stoichiometry: At the start, the solution with a stoichiometry of y = 2.96 contains 200 mg PbAc2 with a perovskite (MAI+PbAc2) weight percentage of 41.8%. For each stoichiometry 2 samples (80 µl) are prepared. The density and the perovskite wt% was determined beforehand for all stoichiometries. Thus, the remaining weight of PbAc2 after each variation step and with that the required amount of MAI/DMF stock solution (with 332.1 mg/ml MAI and 29 wt%) to obtain the desired stoichiometry could be calculated. Figure S7 . I/Pb atomic ratio determined by EDX measurements performed at 10 kV (black) and 6 kV (red) as well as a fit to the corresponding XPS data in Fig. 2d Figure S18 . Preliminary storage stability investigation of PbAc2-based devices in the standard architecture ( Fig. S15) , showing that the initially most efficient overstoichiometric devices with y = 3.03 are degrading much faster when compared to the very stable devices with y ~ 2.99. The unencapsulated devices were stored in air in dark (~40-50% RH) between the measurements.
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